Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease. [PDF]
Huey J +11 more
europepmc +1 more source
Losartan API and Nitrosamines Impurities-Stability Profile Investigation Using HPLC, LC-MS, and In Silico Assessment. [PDF]
Martini PRR +6 more
europepmc +1 more source
Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing. [PDF]
Chałupczyńska B +18 more
europepmc +1 more source
Naturally occurring lysosomal storage disease consistent with neuronal ceroid lipofuscinosis in a group of 5 related captive rhesus macaques (<i>Macaca mulatta</i>). [PDF]
Olstad K +5 more
europepmc +1 more source
Miglustat in Neuronopathic Lysosomal Storage Disorders: Biological Rationale, Clinical Evidence, and Limits of Repurposing. [PDF]
Lipiński P, Węgrzyn G.
europepmc +1 more source
Nerandomilast as the first PDE4B-selective therapy in idiopathic pulmonary fibrosis. [PDF]
Ibrahim M, Piazza GA, Ahsan F.
europepmc +1 more source
An Altered Secretome Is an Early Marker of the Pathogenesis of CLN6 Batten Disease. [PDF]
AbstractNeuronal ceroid lipofuscinoses (NCLs) are a group of inherited childhood neurodegenerative disorders. In addition to the accumulation of auto‐fluorescent storage material in lysosomes, NCLs are largely characterised by region‐specific neuroinflammation that can predict neuron loss.
Hannah L Best +2 more
exaly +3 more sources

